Estée Lauder Companies Aktie
WKN: 897933 / ISIN: US5184391044
|
26.02.2025 17:16:09
|
Estée Lauder Partners With Serpin Pharma To Advance Skin Care Innovation
(RTTNews) - Estee Lauder Companies (EL), Wednesday announced that it has partnered with biotechnology firm Serpin Pharma to explore using advanced anti-inflammatory research in skin care products.
Serpin Pharma's proprietary technology, based on SERPIN proteins, enhances the body's natural healing process to reduce inflammation, skin aging, and sensitivity.
The collaboration supports Estee Lauder's 'Beauty Reimagined' strategy, which focuses on innovative, fast-to-market solutions. Ongoing scientific studies aim to apply this technology to cosmetic products for visible improvements in skin health.
EL is currently trading at $74.27, up 0.45 percent or $0.34 on the New York Stock Exchange.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Estée Lauder Companies Inc. (ELC) (Estee Lauder)mehr Nachrichten
Analysen zu Estée Lauder Companies Inc. (ELC) (Estee Lauder)mehr Analysen
Aktien in diesem Artikel
| Estée Lauder Companies Inc. (ELC) (Estee Lauder) | 59,00 | -1,99% |
|
Letzte Top-Ranking Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.